1
|
Sayhi S, Bouzidi S, Beji I, Nasr AA, Hannachi S, Bedoui I, Layouni S, Fekih-Mrissa N, Louzir B, Nsiri B, Abid R, Battikh R. Neuro-meningeal cryptococcal infection revealing a multiple myeloma. Pan Afr Med J 2020; 36:324. [PMID: 33193978 PMCID: PMC7603827 DOI: 10.11604/pamj.2020.36.324.20407] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2019] [Accepted: 05/25/2020] [Indexed: 11/11/2022] Open
Abstract
Rare cases of Cryptococcus have been documented in patients living with multiple myeloma. To date there has been no documented evidence of cryptococcosis revealing multiple myeloma. We reported a 63-year-old man who had a 2-months history continuous holocranial headaches, morning vomiting, complaining of blurred vision and fever. The biologic and the imaging showed a Cryptococcus meningoencephalitis. The search for a cause of immunodeficiency revealed a multiple myeloma. The diagnosis for Cryptococcus was confirmed according to an India ink stain, blood and cerebrospinal fluid culture. The patient's treatment for multiple myeloma was initiated with a chemotherapy regimen. The evolution was good without complication. Cryptococcosis, especially in the neuro-meningeal form, is a serious, deadly opportunistic infection. The search of an underlining immunodeficiency must be systematic. In this case, it was associated with early stage multiple myeloma.
Collapse
Affiliation(s)
- Sameh Sayhi
- Department of Internal Medicine, Military Hospital, Tunis, Tunisia
| | - Sawsen Bouzidi
- Laboratory of Hematology, Military Hospital, Tunis, Tunisia
| | - Imen Beji
- Department of Internal Medicine, Military Hospital, Tunis, Tunisia
| | | | - Souha Hannachi
- Department of Internal Medicine, Military Hospital, Tunis, Tunisia
| | - Ines Bedoui
- Department of Neurology, Military Hospital, Tunis, Tunisia
| | - Samy Layouni
- Laboratory of Hematology, Military Hospital, Tunis, Tunisia.,Molecular Biology Unit (UR17DN06), Laboratory of Hematology, Military Hospital, Tunis, Tunisia
| | - Najiba Fekih-Mrissa
- Molecular Biology Unit (UR17DN06), Laboratory of Hematology, Military Hospital, Tunis, Tunisia
| | - Bassem Louzir
- Department of Internal Medicine, Military Hospital, Tunis, Tunisia
| | - Brahim Nsiri
- Laboratory of Hematology, Military Hospital, Tunis, Tunisia
| | - Rym Abid
- Department of Internal Medicine, Military Hospital, Tunis, Tunisia
| | - Riadh Battikh
- Department of Internal Medicine, Military Hospital, Tunis, Tunisia
| |
Collapse
|
2
|
Bouzidi S, Daiki M, Nasr AA, Nsiri K, Layouni S, Hajjej Z, Fekih-Mrissa N, Ferjani M, Nsiri B. [Disseminated intravascular coagulation: role of the International Society on Thrombosis and Haemostasis (ISTH) diagnostic scoring system]. Pan Afr Med J 2020; 36:154. [PMID: 32874418 PMCID: PMC7436632 DOI: 10.11604/pamj.2020.36.154.20368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2019] [Accepted: 05/25/2020] [Indexed: 11/11/2022] Open
Abstract
La coagulation intravasculaire disséminée (CIVD) est une cause de mortalité redoutable en milieu de réanimation. L´utilisation du système de score de la société internationale sur la thrombose et l´hémostase (ISTH) permet de faciliter le diagnostic précoce de la CIVD. Nous présentons trois observations cliniques de CIVD d´étiologies différentes: un adénocarcinome prostatique, un choc septique et un hématome rétro-placentaire. Les tests d´hémostase nécessaires au calcul du score de la Société Internationale sur la Thrombose et l´Hémostase (ISTH) (numération plaquettaire, taux de prothrombine, fibrinogène et D-dimères) ont été régulièrement réalisés. D´autres tests complémentaires (recherche de complexes solubles, test de lyse des euglobulines, dosage des taux d´antithrombine, de protéine C activée et du facteur V) ont été également réalisés. L´utilisation du score ISTH permet de faciliter le diagnostic précoce de la CIVD.
Collapse
Affiliation(s)
- Sawsen Bouzidi
- Laboratoire d´Hématologie, Hôpital Militaire Principal d´Instruction de Tunis, Tunis, Tunisie
| | - Mayssa Daiki
- Service d´Anesthésie Réanimation, Hôpital Militaire Principal d´Instruction de Tunis, Tunis, Tunisie
| | - Amen Allah Nasr
- Laboratoire d´Hématologie, Hôpital Militaire Principal d´Instruction de Tunis, Tunis, Tunisie
| | - Kaouther Nsiri
- Laboratoire d´Hématologie, Hôpital Militaire Principal d´Instruction de Tunis, Tunis, Tunisie
| | - Samy Layouni
- Unité de Recherche de Biologie Moléculaire (UR17DN06), Laboratoire d´Hématologie, Hôpital Militaire Principal d´Instruction de Tunis, Tunis, Tunisie
| | - Zied Hajjej
- Service d´Anesthésie Réanimation, Hôpital Militaire Principal d´Instruction de Tunis, Tunis, Tunisie
| | - Najiba Fekih-Mrissa
- Unité de Recherche de Biologie Moléculaire (UR17DN06), Laboratoire d´Hématologie, Hôpital Militaire Principal d´Instruction de Tunis, Tunis, Tunisie
| | - Mustapha Ferjani
- Service d´Anesthésie Réanimation, Hôpital Militaire Principal d´Instruction de Tunis, Tunis, Tunisie
| | - Brahim Nsiri
- Laboratoire d´Hématologie, Hôpital Militaire Principal d´Instruction de Tunis, Tunis, Tunisie
| |
Collapse
|
3
|
Fekih-Mrissa N, Sayeh A, Cheikh C, Oumaya A, Galleli S. Contribution de la mutation C677T dans la persistance des signes négatifs dans la schizophrénie en Tunisie. Eur Psychiatry 2020. [DOI: 10.1016/j.eurpsy.2013.09.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Abstract
IntroductionLe trouble schizophrénique se subdivise, en signes positifs et négatifs. Les symptômes négatifs (S−) sont hétérogènes, reflétant à la fois les symptômes intrinsèques à la schizophrénie, des symptômes résultant d’une dépression concomitante ou distraction en raison des symptômes positifs. Récemment, certains facteurs de risque génétiques impliqués dans la persistance des (S−) sont étudiés, notamment la mutation C677T du gène MTHFR.
Patients et méthodesNotre étude a porté sur 60 patients schizophrènes recrutés au service de psychiatrie à l’hôpital militaire principal d’instruction de Tunis. La mutation C677T du gène MTHFR a été étudiée par la technique PCR-RFLP. La digestion enzymatique a été effectuée avec Hinf1.Résultats et discussionNotre étude a révélé que le génotype CT est statistiquement significatif (Δ2 = 15,15, p = 0,001). Ainsi, le génotype CT semble prédisposer à la persistance des (S−) chez les schizophrènes. Ceci peut être expliqué par le rôle que joue le gène MTHFR qui code pour l’enzyme indispensable à la réduction de l’acide folique afin d’être métaboliquement actif. Le folate actif étant impliqué dans la synthèse des neurotransmetteurs notamment la sérotonine, son déficit induit la persistance des (S−).ConclusionLa mutation C677T semble jouer un rôle dans l’étiopathologie de la schizophrénie. Il est nécessaire de mieux l’appréhender afin de mettre en place de nouvelles stratégies de prise en charge de la maladie.
Collapse
|
4
|
Fekih-Mrissa N, Bouzidi S, Nasr A, Bouzguenda S, Layouni S, Msadek F, Nsiri B. A case of iga-kappa multiple myeloma with intracytoplasmic Auer rod-like inclusions. J Appl Hematol 2019. [DOI: 10.4103/joah.joah_43_19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
5
|
Amara A, Mrad M, Sayeh A, Haggui A, Lahideb D, Fekih-Mrissa N, Haouala H, Nsiri B. Association of FV G1691A Polymorphism but not A4070G With Coronary Artery Disease. Clin Appl Thromb Hemost 2017; 24:330-337. [PMID: 29179580 PMCID: PMC6714679 DOI: 10.1177/1076029617744320] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Coronary artery disease (CAD) is one of the chief causes of death in the world. Several
hypotheses have been promoted as for the origin of the disease, among which are genetic
predispositions and/or environmental factors. The aim of this study was to determine the
effect of factor V (FV) gene polymorphisms (Leiden, G1691A [FVL] and HR2 A4070G) and to
analyze their association with traditional risk factors in assessing the risk of CAD. Our
study population included 200 Tunisian patients with symptomatic CAD and a control group
of 300 participants matched for age and sex. All participants were genotyped for the FVL
and HR2 polymorphisms. Multivariate logistic regression was applied to analyze independent
factors associated with the risk of CAD. Our analysis showed that the FVL A allele
frequency (P < 10–3, odds ratio [OR] = 2.81, 95% confidence
interval [CI] = 1.6-4.9) and GA genotype (P < 10–3, OR =
4.03, 95% CI = 2.1-7.6) are significantly more prevalent among patients with CAD compared
to those controls and may be predisposing to CAD. We further found that the FVL mutation
is an independent risk factor whose effect is not modified by other factors (smoking,
diabetes, hypertension, dyslipidemia, and a family history of CAD) in increasing the risk
of the disease. However, analysis of FV HR2 variation does not show any statistically
significant association with CAD. The FVL polymorphism may be an independent risk factor
for CAD. However, further investigations on these polymorphisms and their possible
synergisms with traditional risk factors for CAD could help to ascertain better
predictability for CAD susceptibility.
Collapse
Affiliation(s)
- Ahmed Amara
- 1 Hôpital Militaire de Tunis, Service d'Hématologie, Laboratoire de Biologie Moléculaire, Montfleury, Tunisie.,2 Université Tunis el Manar, Faculté des Sciences de Tunis, Tunisie
| | - Meriem Mrad
- 1 Hôpital Militaire de Tunis, Service d'Hématologie, Laboratoire de Biologie Moléculaire, Montfleury, Tunisie.,2 Université Tunis el Manar, Faculté des Sciences de Tunis, Tunisie
| | - Aicha Sayeh
- 1 Hôpital Militaire de Tunis, Service d'Hématologie, Laboratoire de Biologie Moléculaire, Montfleury, Tunisie.,2 Université Tunis el Manar, Faculté des Sciences de Tunis, Tunisie
| | - Abdeddayem Haggui
- 3 Hôpital Militaire de Tunis, Service de Cardiologie, Montfleury, Tunisie.,4 Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunisie
| | - Dhaker Lahideb
- 3 Hôpital Militaire de Tunis, Service de Cardiologie, Montfleury, Tunisie.,4 Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunisie
| | - Najiba Fekih-Mrissa
- 1 Hôpital Militaire de Tunis, Service d'Hématologie, Laboratoire de Biologie Moléculaire, Montfleury, Tunisie.,5 Académie Militaire Fondouk Jédid, Nabeul, Tunisie
| | - Habib Haouala
- 3 Hôpital Militaire de Tunis, Service de Cardiologie, Montfleury, Tunisie.,4 Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunisie
| | - Brahim Nsiri
- 1 Hôpital Militaire de Tunis, Service d'Hématologie, Laboratoire de Biologie Moléculaire, Montfleury, Tunisie.,6 Université de Monastir, Faculté de Pharmacie, Monastir, Tunisie
| |
Collapse
|
6
|
Fekih-Mrissa N, Mansour M, Sayeh A, Bedoui I, Mrad M, Riahi A, Mrissa R, Nsiri B. The Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and the Risk of Alzheimer's Disease. Am J Alzheimers Dis Other Demen 2017; 32:342-346. [PMID: 28466654 PMCID: PMC10852582 DOI: 10.1177/1533317517705223] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2024]
Abstract
OBJECTIVE The aim of this study was to determine whether plasminogen activator inhibitor 1 (PAI-1) is associated with the risk of Alzheimer's disease (AD) in Tunisian patients. DESIGN AND METHODS We analyzed the genotype and allele frequency distribution of the PAI-1 polymorphism in 60 Tunisian patients with AD and 120 healthy controls. RESULTS The results show a significantly increased risk of AD in carriers of the 4G/4G and 4G/5G genotypes versus the wild-type 5G/5G genotype (4G/4G: 28.33% in patients vs 10.0% in controls; P < 10-3; OR = 8.78; 4G/5G: 55.0% in patients vs 38.33% in controls; OR = 4.45; P < 10-3). The 4G allele was also more frequently found in patients compared with controls; P < 10-3; OR = 3.07. For all participants and by gender, homozygotic carriers (4G/4G) were at an increased risk of AD over heterozygotes and women were at an increased risk over their male genotype counterparts. The odds ratio for AD among 4G/4G carriers for any group was approximately twice that of heterozygotes in the same group. Women homozygotes ranked highest for AD risk (OR = 20.8) and, in fact, women heterozygotes (OR = 9.03) ranked higher for risk than male homozygotes (OR = 6.12). CONCLUSION These preliminary exploratory results should be confirmed in a larger study.
Collapse
Affiliation(s)
- Najiba Fekih-Mrissa
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital of Tunisia, Tunis, Tunisia
| | - Malek Mansour
- Department of Psychiatry, Military Hospital of Tunisia, Tunis, Tunisia
| | - Aicha Sayeh
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital of Tunisia, Tunis, Tunisia
| | - Ines Bedoui
- Department of Psychiatry, Military Hospital of Tunisia, Tunis, Tunisia
| | - Meriem Mrad
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital of Tunisia, Tunis, Tunisia
| | - Anis Riahi
- Department of Psychiatry, Military Hospital of Tunisia, Tunis, Tunisia
| | - Ridha Mrissa
- Department of Psychiatry, Military Hospital of Tunisia, Tunis, Tunisia
| | - Brahim Nsiri
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital of Tunisia, Tunis, Tunisia
| |
Collapse
|
7
|
Nasri A, Mansour M, Kacem A, Derbali H, Yahya M, Riahi A, Bedoui I, Messelmani M, Zaouali J, Fekih-Mrissa N, Bouzayène A, Mrissa R. Trouble obsessionnel compulsif pédiatrique : forme inaugurale inhabituelle de la maladie de Lafora. Encephale 2017; 43:90-94. [DOI: 10.1016/j.encep.2016.06.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2015] [Accepted: 08/31/2015] [Indexed: 11/17/2022]
|
8
|
Sayeh A, Ben Cheikh C, Mardessi A, Mrad M, Nsiri B, Oumaya A, Fekih-Mrissa N. HLA DRB1*03 as a possible common etiology of schizophrenia, Graves' disease, and type 2 diabetes. Ann Gen Psychiatry 2017; 16:7. [PMID: 28174595 PMCID: PMC5290670 DOI: 10.1186/s12991-017-0128-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/22/2016] [Accepted: 01/12/2017] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Autoimmune diseases and schizophrenia share many common features. Association studies confirm a shared genetic association in the human leukocyte antigen (HLA) region between schizophrenia and most autoimmune diseases. To our knowledge, the simultaneous syndromes of Graves' disease (GD) and type 2 diabetes (T2D) in schizophrenia are rare in Tunisia. CASE PRESENTATION We report a case of a 42-year-old woman admitted to the department of psychiatry for an acute relapse of chronic schizophrenia. Her medical history revealed that she was followed for Graves' disease and for a type 2 diabetes mellitus. A low-resolution HLA typing was performed by polymerase chain reaction sequence-specific primer (PCR-SSP) techniques according to determine the patient's haplotype. CONCLUSIONS Our study suggests that the HLA DRB1*03 allele may explain a common etiology underlying the co-morbidity of Graves' disease, type 2 diabetes, and schizophrenia in our patient.
Collapse
Affiliation(s)
- Aicha Sayeh
- Laboratoire de Biologie Moléculaire, Service d'Hématologie., Hôpital Militaire de Tunis, Montfleury, 1008 Tunis, Tunisia.,Faculté des Sciences de Tunis, Université Tunis el Manar, 2092 Tunis, Tunisia
| | - Cheker Ben Cheikh
- Service de Psychiatrie, Hôpital Militaire de Tunis, Montfleury, 1008 Tunis, Tunisia.,Faculté de Médecine de Tunis, Université de Tunis El Manar, 1007 Tunis, Tunisia
| | - Ali Mardessi
- Faculté de Médecine de Tunis, Université de Tunis El Manar, 1007 Tunis, Tunisia.,Service Oto-rhino-laryngologie, Hôpital Militaire de Tunis, Montfleury, 1008 Tunis, Tunisia
| | - Meriem Mrad
- Laboratoire de Biologie Moléculaire, Service d'Hématologie., Hôpital Militaire de Tunis, Montfleury, 1008 Tunis, Tunisia.,Faculté des Sciences de Tunis, Université Tunis el Manar, 2092 Tunis, Tunisia
| | - Brahim Nsiri
- Laboratoire de Biologie Moléculaire, Service d'Hématologie., Hôpital Militaire de Tunis, Montfleury, 1008 Tunis, Tunisia
| | - Abdelaziz Oumaya
- Service de Psychiatrie, Hôpital Militaire de Tunis, Montfleury, 1008 Tunis, Tunisia.,Faculté de Médecine de Tunis, Université de Tunis El Manar, 1007 Tunis, Tunisia
| | - Najiba Fekih-Mrissa
- Laboratoire de Biologie Moléculaire, Service d'Hématologie., Hôpital Militaire de Tunis, Montfleury, 1008 Tunis, Tunisia.,Académie Militaire Fondouk Jédid, 8012 Nabeul, Tunisia
| |
Collapse
|
9
|
Fekih-Mrissa N, Bedoui I, Sayeh A, Derbali H, Mrad M, Mrissa R, Nsiri B. Association between an angiotensin-converting enzyme gene polymorphism and Alzheimer's disease in a Tunisian population. Ann Gen Psychiatry 2017; 16:41. [PMID: 29176997 PMCID: PMC5693601 DOI: 10.1186/s12991-017-0164-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/23/2017] [Accepted: 11/08/2017] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND The angiotensin-converting enzyme gene (ACE) insertion/deletion (I/D or indel) polymorphism has long been linked to Alzheimer's disease (AD), but the interpretation of established data remains controversial. The aim of this study was to determine whether the angiotensin-converting enzyme is associated with the risk of Alzheimer's disease in Tunisian patients. METHODS We analyzed the genotype and allele frequency distribution of the ACE I/D gene polymorphism in 60 Tunisian AD patients and 120 healthy controls. RESULTS There is a significantly increased risk of AD in carriers of the D/D genotype (51.67% in patients vs. 31.67% in controls; p = .008, OR = 2.32). The D allele was also more frequently found in patients compared with controls (71.67% vs. 56.25%; p = .003, OR = 2.0). Moreover, as assessed by the Mini-Mental State Examination, patient D/D carriers were more frequently found to score in the severe category of dementia (65%) as compared to the moderate category (32%) or mild category (3%). CONCLUSIONS The D/D genotype and D allele of the ACE I/D polymorphism were associated with an increased risk in the development of AD in a Tunisian population. Furthermore, at the time of patient evaluation (average age 75 years), patients suffering with severe dementia were found predominantly in D/D carriers and, conversely, the D/D genotype and D allele were more frequently found in AD patients with severe dementia. These preliminary exploratory results should be confirmed in larger studies and further work is required to explore and interpret possible alternative findings in diverse populations.
Collapse
Affiliation(s)
- Najiba Fekih-Mrissa
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital of Tunisia, Mont Fleury, 1008 Tunis, Tunisia
| | - Ines Bedoui
- Department of Neurology, Military Hospital of Tunisia, Montfleury, Tunis, 1008 Tunisia
| | - Aycha Sayeh
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital of Tunisia, Mont Fleury, 1008 Tunis, Tunisia
| | - Hajer Derbali
- Department of Neurology, Military Hospital of Tunisia, Montfleury, Tunis, 1008 Tunisia
| | - Meriem Mrad
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital of Tunisia, Mont Fleury, 1008 Tunis, Tunisia
| | - Ridha Mrissa
- Department of Neurology, Military Hospital of Tunisia, Montfleury, Tunis, 1008 Tunisia
| | - Brahim Nsiri
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital of Tunisia, Mont Fleury, 1008 Tunis, Tunisia
| |
Collapse
|
10
|
Amara A, Mrad M, Sayeh A, Lahideb D, Layouni S, Haggui A, Fekih-Mrissa N, Haouala H, Nsiri B. The Effect of ACE I/D Polymorphisms Alone and With Concomitant Risk Factors on Coronary Artery Disease. Clin Appl Thromb Hemost 2016; 24:157-163. [PMID: 27895197 DOI: 10.1177/1076029616679505] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND Coronary artery disease (CAD), also known as atherosclerotic heart disease, is a leading cause of mortality and morbidity throughout the world. The role of insertion/deletion (I/D) polymorphisms of the angiotensin-converting enzyme (ACE) gene in the etiology of CAD remains to be more completely clarified. The aim of this study was to determine the role of the ACE I/D polymorphism in patients with CAD and to study the association together with traditional risk factors in assessing the risk of CAD. METHODS Our study population included 145 Tunisian patients with symptomatic CAD and a control group of 300 people matched for age and sex. All participants in the study were genotyped for the ACE I/D polymorphisms obtained by polymerase chain reaction amplification on genomic DNA. RESULTS Our analysis showed that the ACE D allele frequency ( P < 10-3; odds ratio [OR] = 5.2; 95% confidence interval [CI] = 3.6-7.6) and DD genotype ( P < 10-3; OR = 6.8; 95% CI = 4.4-10) are significantly more prevalent among patients with CAD than in controls and may be predisposing to CAD. We further found that the risk of CAD is greatly potentiated by several concomitant risk factors (smoking, diabetes, hypertension, dyslipidemia, and a family history of CAD). CONCLUSION The ACE D allele may be predictive in individuals who may be at risk of developing CAD. Further investigations of these polymorphisms and their possible synergisms with traditional risk factors for CAD could help to ascertain better predictability for CAD susceptibility.
Collapse
Affiliation(s)
- Ahmed Amara
- 1 Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire de Tunis, Montfleury, Tunisie.,2 Faculté des Sciences de Tunis, Université Tunis el Manar, Tunis, Tunisie
| | - Meriem Mrad
- 1 Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire de Tunis, Montfleury, Tunisie.,2 Faculté des Sciences de Tunis, Université Tunis el Manar, Tunis, Tunisie
| | - Aicha Sayeh
- 1 Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire de Tunis, Montfleury, Tunisie.,2 Faculté des Sciences de Tunis, Université Tunis el Manar, Tunis, Tunisie
| | - Dhaker Lahideb
- 3 Service de Cardiologie, Hôpital Militaire de Tunis, Montfleury, Tunisie.,4 Faculté de Médecine de Tunis, Université de Tunis El Manar, Tunis, Tunisie
| | - Samy Layouni
- 1 Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire de Tunis, Montfleury, Tunisie.,5 Faculté de Pharmacie, Université de Monastir, Monastir, Tunisie
| | - Abdeddayem Haggui
- 3 Service de Cardiologie, Hôpital Militaire de Tunis, Montfleury, Tunisie.,4 Faculté de Médecine de Tunis, Université de Tunis El Manar, Tunis, Tunisie
| | - Najiba Fekih-Mrissa
- 1 Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire de Tunis, Montfleury, Tunisie.,6 Académie Militaire Fondouk Jédid, Nabeul, Tunisie
| | - Habib Haouala
- 3 Service de Cardiologie, Hôpital Militaire de Tunis, Montfleury, Tunisie.,4 Faculté de Médecine de Tunis, Université de Tunis El Manar, Tunis, Tunisie
| | - Brahim Nsiri
- 1 Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire de Tunis, Montfleury, Tunisie.,5 Faculté de Pharmacie, Université de Monastir, Monastir, Tunisie
| |
Collapse
|
11
|
Fekih-Mrissa N, Sayeh A, Baffoun A, Beji M, Mrad M, Hmida J, Nsiri B. Association Between Thrombophilic Gene Mutations and the Risk of Vascular Access Thrombosis in Hemodialysis Patients. Ther Apher Dial 2016; 20:107-11. [PMID: 27004938 DOI: 10.1111/1744-9987.12379] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2015] [Revised: 09/23/2015] [Accepted: 09/25/2015] [Indexed: 11/28/2022]
Abstract
The cause of thrombosis in hemodialysis vascular access is considered to be of a multifactorial nature, including stenosis of the venous or arterial connection. Therefore, identification of relevant thrombotic risk factors could lead to an improved antithrombotic therapy. This case control study was performed to evaluate the relationship between Factor V (G1691A and A4070G) and Factor II polymorphisms and vascular access thrombosis in hemodialysis patients. One hundred and twenty-one patients undergoing dialysis were selected as subjects. This sample was divided into two groups; a case group of 60 patients who had sustained one or more thrombotic events that resulted in vascular access failure and a control group of 61 patients, who never had a thrombotic occlusion of a functioning permanent dialysis access. Our data demonstrated a significantly increased risk of vascular access thrombosis in carriers of the mutant FV (G1691A and A4070G) polymorphisms (P < 0.05).Further studies on a large-scale population and other genetic variants will be needed to find candidate genes for vascular access thrombosis in hemodialysis patients.
Collapse
Affiliation(s)
| | - Aycha Sayeh
- Laboratory of Molecular Biology, Department of Hematology
| | - Anis Baffoun
- Department of Hemodialysis, Military Hospital of Tunisia, Tunis, Tunisia
| | - Maher Beji
- Department of Hemodialysis, Military Hospital of Tunisia, Tunis, Tunisia
| | - Meriem Mrad
- Laboratory of Molecular Biology, Department of Hematology
| | - Jalel Hmida
- Department of Hemodialysis, Military Hospital of Tunisia, Tunis, Tunisia
| | - Brahim Nsiri
- Laboratory of Molecular Biology, Department of Hematology
| |
Collapse
|
12
|
Mrad M, Fekih-Mrissa N, Wathek C, Sayeh A, Maalej A, Rannen R, Nsiri B. Role of the Apolipoprotein E Polymorphisms in the Development of Retinal Vein Occlusion in a Tunisian Population: A Case–Control Study. Clin Appl Thromb Hemost 2016; 23:645-651. [DOI: 10.1177/1076029616629212] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Apolipoprotein E ( APOE) is a member of the apolipoprotein gene family. APOE is polymorphic with 3 main allelic types: ∊2, ∊3, and ∊4. Certain of these alleles have been associated with higher vascular risk. However, the association of APOE genotypes with retinal biomarkers and risk of retinal stroke is less clear. This study evaluated the role of APOE polymorphisms in retinal vein occlusion (RVO). In the present study, 2-point mutations coding amino acid residues 112 and 158 were amplified using the polymerase chain reaction (PCR) from DNA extracted from Tunisian participants. APOE genotypes were determined by multiplex PCR followed by molecular hybridization. Eighty-eight patients (26 women and 62 men) and 100 age- and gender-matched healthy participants were enrolled. The statistical study revealed a higher frequency of the ∊4 allele in patients as compared to controls (27.3% vs 9%) with a significant association of the ∊4 allele with the disease ( P < 10−3, Pa < 10−3, odds ratio [OR] = 3.8, 95% confidence interval [CI] = 2.1-6.8). The frequency of the ∊3 allele was significantly lower in the patients with RVO compared to the controls (60.2% vs 82.5%, respectively; P < 10−3, Pa < 10−3, OR = 0.32, 95% CI = 0.19-0.53). The ∊3 allele seems to be protective against the disease. There was no association between the APO ∊2 allele and RVO. The association of APOE allele and genotype with RVO requires further investigation in different populations.
Collapse
Affiliation(s)
- Meriem Mrad
- Laboratoire de Biologie Moléculaire, Service d’Hématologie Hôpital Militaire Principal d’Instruction de Tunis, Montfleury, Tunisie
- Faculté des Science de Tunis, Université Tunis el Manar, El Manar, Tunisie
| | - Najiba Fekih-Mrissa
- Laboratoire de Biologie Moléculaire, Service d’Hématologie Hôpital Militaire Principal d’Instruction de Tunis, Montfleury, Tunisie
- Académie Militaire Fondouk Jédid, Nabeul, Tunisie
| | - Cheima Wathek
- Service d’Ophtalmologie, Hôpital Militaire Principal d’Instruction de Tunis, Montfleury, Tunisie
- Faculté de Médecine de Tunis, Université Tunis el Manar, Tunis, Tunisie
| | - Aicha Sayeh
- Laboratoire de Biologie Moléculaire, Service d’Hématologie Hôpital Militaire Principal d’Instruction de Tunis, Montfleury, Tunisie
- Faculté des Science de Tunis, Université Tunis el Manar, El Manar, Tunisie
| | - Afef Maalej
- Service d’Ophtalmologie, Hôpital Militaire Principal d’Instruction de Tunis, Montfleury, Tunisie
- Faculté de Médecine de Tunis, Université Tunis el Manar, Tunis, Tunisie
| | - Riadh Rannen
- Service d’Ophtalmologie, Hôpital Militaire Principal d’Instruction de Tunis, Montfleury, Tunisie
- Faculté de Médecine de Tunis, Université Tunis el Manar, Tunis, Tunisie
| | - Brahim Nsiri
- Laboratoire de Biologie Moléculaire, Service d’Hématologie Hôpital Militaire Principal d’Instruction de Tunis, Montfleury, Tunisie
- Faculté de Pharmacie, Université de Monastir, Monastir, Tunisie
| |
Collapse
|
13
|
Touati N, Mansour M, Bedoui I, Kacem A, Derbali H, Riahi A, Messelmani M, Zaouali J, Fekih-Mrissa N, Mrissa R. [Neurologic manifestations of sarcoidosis: A study of 18 cases]. Rev Neurol (Paris) 2015; 171:773-81. [PMID: 26648345 DOI: 10.1016/j.neurol.2015.07.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2014] [Revised: 07/13/2015] [Accepted: 07/22/2015] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Sarcoidosis is a multisystemic granulomatous disease of unknown aetiology. Neurologic manifestations are found in 5 to 10% of cases. PATIENTS AND METHODS We conducted a retrospective study over 6-year period including 18 patients diagnosed with neurosarcoidosis in the Neurologic department of the Military Hospital of Instruction of Tunis. Clinical, radiological, therapeutic features and outcome were studied. RESULTS The mean age was 43.44 years. Neurologic signs were the first symptom in 10 cases. Peripheral nervous system impairment was often found. Meningitis was noted in 8 cases. Biological tests are not contributive for the diagnosis. The brain magnetic resonance imaging was pathologic in 10 cases. Corticosteroids were administrated in the majority of cases. Eight patients did not show any sign of improvement. Ten cases improved with treatment. DISCUSSION AND CONCLUSION Diagnosis of neurosarcoidosis is difficult because of its clinical and radiological polymorphism. It is based on a clinical history suggestive of neurosarcoidosis, laboratory, imaging and histological studies.
Collapse
Affiliation(s)
- N Touati
- Service de neurologie, hôpital militaire principal d'instruction de Tunis, Mont Fleury, 1008 Tunis, Tunisie.
| | - M Mansour
- Service de neurologie, hôpital militaire principal d'instruction de Tunis, Mont Fleury, 1008 Tunis, Tunisie
| | - I Bedoui
- Service de neurologie, hôpital militaire principal d'instruction de Tunis, Mont Fleury, 1008 Tunis, Tunisie
| | - A Kacem
- Service de médecine, hôpital régional de Jendouba, avenue de l'UMA 8100, Jendouba, Tunisie
| | - H Derbali
- Service de neurologie, hôpital militaire principal d'instruction de Tunis, Mont Fleury, 1008 Tunis, Tunisie
| | - A Riahi
- Service de neurologie, hôpital militaire principal d'instruction de Tunis, Mont Fleury, 1008 Tunis, Tunisie
| | - M Messelmani
- Service de neurologie, hôpital militaire principal d'instruction de Tunis, Mont Fleury, 1008 Tunis, Tunisie
| | - J Zaouali
- Service de neurologie, hôpital militaire principal d'instruction de Tunis, Mont Fleury, 1008 Tunis, Tunisie
| | - N Fekih-Mrissa
- Service d'hématologie, hôpital militaire principal d'instruction de Tunis, Mont Fleury, 1008 Tunis, Tunisie
| | - R Mrissa
- Service de neurologie, hôpital militaire principal d'instruction de Tunis, Mont Fleury, 1008 Tunis, Tunisie
| |
Collapse
|
14
|
Abstract
We describe the case of a patient with confirmed limbic encephalitis associated with leucine-rich glioma-inactivated 1 (LGI1) antibodies. A 59-year-old man presented to the Department of Neurology with bizarre behavior, memory loss, cognitive impairment, visual hallucinations, and myoclonus and facio-brachial dystonic seizures. A brain magnetic resonance imaging (MRI) revealed no hippocampal lesions. Blood tests showed hyponatremia. An electroencephalogram showed disorganization and slowing of background activity. Antiepileptic drugs were ineffective. The patient exhibited considerable improvement following immunotherapy. The diagnosis of limbic encephalitis associated with LGI1 antibodies should be considered in patients with clinical manifestations mimicking psychiatric disorders and in cases of refractory epilepsy especially with faciobrachial dystonic seizures. There is frequently hyponatremia, and cerebral MRI may be normal. Full recovery can be expected with early diagnosis and prompt treatment.
Collapse
Affiliation(s)
- Mariem Messelmani
- Mariem Messelmani, Department of Neurology,, Military Hospital 1008, Mont Fleury Tunis, Tunisia, T: +21699954557,
| | | | | | | |
Collapse
|
15
|
Sayeh A, Cheikh CB, Mrad M, Lakhal N, Gritli N, Galelli S, Oumaya A, Fekih-Mrissa N. Association of HLA-DR/DQ polymorphisms with schizophrenia in Tunisian patients. Ann Saudi Med 2014; 34:503-7. [PMID: 25971824 PMCID: PMC6074579 DOI: 10.5144/0256-4947.2014.503] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND AND OBJECTIVES The hypothesis that human leukocyte antigens (HLAs) confer susceptibility to schizophrenic disorders has been tested by studying linkage and association in family samples. Our goal was to evaluate the role of HLA in the risk of developing schizophrenia in a Tunisian population. DESIGN AND SETTINGS Blood samples for this case-control study were collected from patients of the Department of Psychiatry at the Military Hospital of Tunisia between July 2012 and May 2013. METHODS A total of 140 patients with schizophrenia were recruited for genetic analysis. Controls included 100 persons matched for age, sex, and risk factors. Participants were tested for HLA class II alleles. HLA-DRB1 and HLA-DQB1 alleles were genotyped using polymerase chain reaction sequence-specific primers. RESULTS This study indicates that the alleles most responsible for disease susceptibility are DRB1*03 (P < 10-3) and DQB1*02 (P < 10-3) (P denotes probability values). The most protective alleles are DRB1*13 (P=.013) and DQB1*05 (P < 10-3). Further results revealed that DRB1*0301/DQB1*0201(P < 10-3), DRB1*0401/DQB1*0301 (P < 10-3) and DRB1*1101/DQB1*0301 (P < 10-3) are haplotypes most conducive to disease susceptibility. CONCLUSION The present findings support an association between schizophrenia and the HLA-DR-DQ locus among a Tunisian population. To our knowledge, this is the first study performed to analyze the association of HLA DRB1/DQB1 alleles on schizophrenia susceptibility in Tunisia.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Najiba Fekih-Mrissa
- Najiba Fekih-Mrissaa, MD, Department of Hematology,, Laboratory of Molecular Biology,, Military Hospital of Tunisia,, Tunis 1008, Tunisia, T: +21622510488,, F: +21670762084,
| |
Collapse
|
16
|
Fekih-Mrissa N, Mrad M, Haggui A, Layouni S, Lahidheb D, Haouala H, Gritli N. Mthfr (c677t and a1298c) polymorphisms and coronary heart disease. Atherosclerosis 2014. [DOI: 10.1016/j.atherosclerosis.2014.05.416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
17
|
Fekih-Mrissa N, Mrad M, Riahi A, Sayeh A, Zaouali J, Gritli N, Mrissa R. Association of HLA-DR/DQ polymorphisms with Guillain–Barré syndrome in Tunisian patients. Clin Neurol Neurosurg 2014; 121:19-22. [DOI: 10.1016/j.clineuro.2014.03.014] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2013] [Revised: 01/20/2014] [Accepted: 03/10/2014] [Indexed: 11/24/2022]
|
18
|
Mrad M, Wathek C, Saleh MB, Baatour M, Rannen R, Lamine K, Gabsi S, Gritli N, Fekih-Mrissa N. Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients. Transfus Apher Sci 2014; 50:283-7. [DOI: 10.1016/j.transci.2013.12.016] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2013] [Revised: 12/22/2013] [Accepted: 12/24/2013] [Indexed: 01/16/2023]
|
19
|
Mrad M, Fekih-Mrissa N, Wathek C, Rannen R, Gabsi S, Gritli N. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients. J Stroke Cerebrovasc Dis 2014; 23:1592-8. [PMID: 24630828 DOI: 10.1016/j.jstrokecerebrovasdis.2013.12.048] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2013] [Revised: 10/30/2013] [Accepted: 12/29/2013] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND Retinal vein occlusion (RVO) is the second most common cause of vision loss because of retinal vascular disease. There are 2 types of RVO: branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). The pathogenesis of RVO is multifactorial. The role of factor V Leiden (FVL) and prothrombin mutations was examined in patients with CRVO and BRVO. METHODS FVL and prothrombin were investigated by extracting DNA of 88 patients with RVO. Sixteen of the patients were diagnosed with CRVO, 4 with hemispheric retinal vein occlusion, and 68 with BRVO. The genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism. RESULTS Significant differences were found in the frequencies of the genotypes for both the FVL (G1691A) (P<10(-3), odds ratio [OR]=17.4, confidence interval [CI]=6.20-59) and prothrombin (G20210A) (P=.007, OR=5.11, CI=1.30-29) polymorphisms between RVO patients and healthy controls. Additionally, the frequency of the GA genotype for the G1691A polymorphism was significantly higher among the patients in a subset of BRVO compared with controls (P<10(-3), OR=21.4, CI=7.34-74.2). However, no statistically significant differences were found in the frequencies of the prothrombin G20210A polymorphism between the BRVO group and healthy controls (P=.09, OR=3.13, CI=64-19.9). The frequency of both G1691A and G20210A genotypes among the patients of a CRVO subgroup was significantly higher compared with controls (P<10(-3), OR=11.4, CI=2.94-44.2; P=.007, OR=10.8, CI=2.15-54.1, respectively), suggesting an association between these polymorphisms and CRVO. CONCLUSIONS Large study would be required to understand completely the contribution of these markers in the risk of all types of RVO.
Collapse
Affiliation(s)
- Meriem Mrad
- Faculté des Science de Tunis, Université Tunis el Manar, El Manar, Tunisie; Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunisie
| | - Najiba Fekih-Mrissa
- Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunisie; Académie Militaire Fondouk Jédid, Nabeul, Tunisie.
| | - Cheima Wathek
- Faculté de Médecine de Tunis, Université Tunis el Manar, Tunis, Tunisie; Service d'Ophtalmologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunisie
| | - Riadh Rannen
- Faculté de Médecine de Tunis, Université Tunis el Manar, Tunis, Tunisie; Service d'Ophtalmologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunisie
| | - Salem Gabsi
- Faculté de Médecine de Tunis, Université Tunis el Manar, Tunis, Tunisie; Service d'Ophtalmologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunisie
| | - Nasreddine Gritli
- Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunisie; Faculté de Pharmacie, Université de Monastir, Monastir, Tunisie
| |
Collapse
|
20
|
Fekih-Mrissa N, Mrad M, Klai S, Mansour M, Nsiri B, Gritli N, Mrissa R. Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients. J Stroke Cerebrovasc Dis 2013; 22:465-9. [PMID: 23642756 DOI: 10.1016/j.jstrokecerebrovasdis.2013.03.011] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2012] [Revised: 01/17/2013] [Accepted: 03/09/2013] [Indexed: 11/18/2022] Open
Abstract
OBJECTIVE The present study evaluated the role of the methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C gene polymorphisms and correlated these results with plasma homocysteine (Hcy) levels in Tunisian ischemic stroke (IS) patients. METHODS Overall, 84 patients with IS were included and compared with 100 healthy controls. The most common stroke risk factors were investigated. Fasting plasma Hcy levels were measured. Genotyping of the MTHFR C677T and A1298 polymorphisms was studied by polymerase chain reaction. RESULTS Aside from tobacco and alcohol use, the other studied factors were significant risk factors for IS. Mean plasma Hcy levels were significantly higher in IS patients than in controls (16.1 ± 8.28 μmol/L versus 8.76 ± 3.48 μmol/L, P < 10(-3)). Significant associations were found with both the MTHFR 677(CT + TT) and 1298 (AC + CC) genotypes in comparison with controls (P < 10(-3)). A significant synergistic interaction was also found with the double heterozygote MTHFR 677CT/1298AC (P < 10(-3)). Homocysteine levels were significantly higher in IS patients with the MTHFR C677T variant (CT and TT genotypes) (P < 10(-3)); however, the difference was not significant with the MTHFR A1298C variant (AC and CC genotypes) (P = .31). CONCLUSION The MTHFR C677T and A1298 polymorphisms (individually or in concert) and hyperhomocysteinemia represent important risk factors for IS. Elevated Hcy levels were found to be associated with the MTHFR C677T variant; however, no significant association was found with the MTHFR A1298C variant.
Collapse
Affiliation(s)
- Najiba Fekih-Mrissa
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital, Tunisia.
| | | | | | | | | | | | | |
Collapse
|
21
|
Mrad M, Fekih-Mrissa N, Mansour M, Seyah A, Riahi A, Gritli N, Mrissa R. Association of HLA-DR/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients. Transfus Apher Sci 2013; 49:623-6. [DOI: 10.1016/j.transci.2013.07.024] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2013] [Accepted: 07/26/2013] [Indexed: 11/28/2022]
|
22
|
Fekih-Mrissa N, Klai S, Mrad M, Mansour M, Zaouali J, Gritli N, Mrissa R. Apolipoprotein E genotypes associated with Alzheimer disease and concomitant stroke. J Stroke Cerebrovasc Dis 2013; 23:681-5. [PMID: 23871727 DOI: 10.1016/j.jstrokecerebrovasdis.2013.06.018] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2013] [Revised: 05/20/2013] [Accepted: 06/08/2013] [Indexed: 10/26/2022] Open
Abstract
BACKGROUND The ɛ4 allele of the apolipoprotein E (APOE) gene is a well-characterized genetic risk factor for Alzheimer disease (AD). The association between stroke and a higher risk for AD has also been reported. Our study sought to determine the relationship between the APOE gene and AD and the comorbid risk of stroke. METHODS The subjects of this study consisted of 48 patients with AD and 48 members of a control group. All subjects were genotyped for APOE. RESULTS The results clearly show a significant increased risk of AD in carriers of the APOE ε3/ε4 genotype (P = .003, odds ratio [OR] = 4.1) or ε4 allele (P = .001, OR = 4.2). The risk for stroke in AD patients was also increased for carriers of the APOE ε3/ε4 genotype (P = .02, OR = 9.0) and for carriers of the APOE ε4 allele (P = .004, OR = 5.5). CONCLUSIONS The present study is the first to establish a relationship between APOE ε4 and concomitant AD and stroke in the Tunisian population.
Collapse
Affiliation(s)
- Najiba Fekih-Mrissa
- Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunis, Tunisie; Académie Militaire Fondouk Jédid, Nabeul, Tunisie.
| | - Sarra Klai
- Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunis, Tunisie; Faculté des Sciences de Tunis, Université de Tunis El Manar, El Manar, Tunisie
| | - Meriem Mrad
- Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunis, Tunisie; Faculté des Sciences de Tunis, Université de Tunis El Manar, El Manar, Tunisie
| | - Malek Mansour
- Service de Neurologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunis, Tunisie; Faculté de Médecine de Tunis, Université de Tunis El Manar, Tunis, Tunisie
| | - Jamel Zaouali
- Service de Neurologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunis, Tunisie; Faculté de Médecine de Tunis, Université de Tunis El Manar, Tunis, Tunisie
| | - Nasreddine Gritli
- Laboratoire de Biologie Moléculaire, Service d'Hématologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunis, Tunisie; Faculté de Pharmacie, Université de Monastir, Monastir, Tunisie
| | - Ridha Mrissa
- Service de Neurologie, Hôpital Militaire Principal d'Instruction de Tunis, Montfleury, Tunis, Tunisie; Faculté de Médecine de Tunis, Université de Tunis El Manar, Tunis, Tunisie
| |
Collapse
|
23
|
Mansouri L, Fekih-Mrissa N, Klai S, Mansour M, Gritli N, Mrissa R. Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer's disease. Clin Neurol Neurosurg 2013; 115:1693-6. [PMID: 23659764 DOI: 10.1016/j.clineuro.2013.03.015] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2012] [Revised: 03/15/2013] [Accepted: 03/25/2013] [Indexed: 10/26/2022]
Abstract
BACKGROUND Genetic risk factors play an important role in the pathogenesis of Alzheimer's disease (AD). In this case-control study, we examined the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene and their correlation with this pathology. OBJECTIVE To verify the association between MTHFR C677T and A1298C polymorphisms and Alzheimer's disease. METHOD This work was conducted as a case-control study. Cases consisted of thirty-eight patients and 100 individuals without dementia constituted the control group. Genotyping of MTHFR polymorphisms was performed on patients and controls. RESULT Genetic analyses did not indicate a significant association between the MTHFR C677T mutation and AD (C/T: 63.15% versus 39%, p=0.087). However, the genotype prevalence of the missense variant MTHFR A1298C was significantly different between patients and controls (A/C: 55% versus 7%, p<10(-3)). Our data suggest an association between the MTHFR A1298C mutation and AD; however, the MTHFR C677T mutation did not contribute to susceptibility for AD. CONCLUSION The MTHFR A1298C polymorphism is a possible risk factor for Alzheimer's disease.
Collapse
Affiliation(s)
- Leila Mansouri
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital, Tunis, Tunisia
| | | | | | | | | | | |
Collapse
|
24
|
Blanco-Gozalo V, Blazquez-Medela A, Garcia-Sanchez O, Quiros Y, Montero M, Martinez-Salgado C, Lopez-Hernandez F, Lopez-Novoa J, Yao L, Qing Z, Hua X, Min F, Fei M, Ning W, Cantaluppi V, Figliolini F, Delena M, Beltramo S, Medica D, Tetta C, Segoloni G, Biancone L, Camussi G, Cunha JS, Ferreira VM, Naves MA, Boim MA, Zitman-Gal T, Golan E, Green J, Pasmanik-Chor M, Bernheim J, Benchetrit S, Riera M, Clotet S, Pascual J, Soler M, Nakai K, Fujii H, Kono K, Goto S, Hirata M, Shinohara M, Fukagawa M, Nishi S, Fan Q, Du S, Jiang Y, Wang L, Fang L, Radovits T, Mozes MM, Rosivall L, Kokeny G, Aoki R, Tateoka R, Sekine F, Kikuchi K, Yamashita Y, Itoh Y, Cappuccino L, Garibotto G, D'Amato E, Villaggio B, Gianiorio F, Mij M, Viazzi F, Salvidio G, Verzola D, Piwkowska A, Rogacka D, Audzeyenka I, Kasztan M, Angielski S, Jankowski M, Gaber EW, El-Attar HA, Liu J, Zhang W, He Y, Rogacka D, Piwkowska A, Audzeyenka I, Angielski S, Jankowski M, Macsai E, Takats Z, Derzbach L, Korner A, Vasarhelyi B, Huang MS, Bo H, Liu F, Fu P, Tsotakos NE, Tsilibary EC, Drossopoulou GI, Thawho N, Farid N, Peleg A, Levy A, Nakhoul N, Lenghel AR, Borza G, Catoi C, Bondor CI, Muresan A, Kacso IM, Song JS, Song JH, Ahn SH, Choi BS, Hong YA, Kim MY, Lim JH, Yang KS, Chung S, Shin SJ, Kim HW, Chang YS, Kim YS, Park CW, Takayanagi K, Hasegawa H, Shimizu T, Ikari A, Noiri C, Iwashita T, Tayama Y, Asakura J, Anzai N, Kanozawa K, Kato H, Mitarai T, Huang M, Bo H, Liu F, Fu P, Ashour RH, Fouda AEMM, Saad MA, El-Banna FM, Moustafa FA, Fouda MI, Sanchez-Nino MD, Sanz AB, Poveda J, Saleem M, Mathieson P, Ruiz-Ortega M, Selgas R, Egido J, Ortiz A, Clotet S, Soler MJ, Rebull M, Pascual J, Riera M, Marquez E, Riera M, Pascual J, Soler MJ, Asakura J, Hasegawa H, Takayanagi K, Tayama Y, Shimizu T, Iwashita T, Okazaki S, Kogure Y, Sano T, Hatano M, Kanozawa K, Kato H, Mitarai T, Kreft E, Kowalski R, Kasztan M, Jankowski M, Szczepansk-Konkel M, Fan Q, Liu X, Yang G, Jiang Y, Wang L, Osman NA, NasrAllah MM, Kamal MM, Ahmed AI, Fekih-Mrissa N, Mrad M, Baffoun A, Sayeh A, Hmida J, Gritli N, Galchinskaya V, Topchii I, Semenovykh P, Yefimova N, Zheng D, Hu D, Li X, Peng AI, Olea-Herrero N, Arenas M, Munoz-Moreno C, Moreno-Gomez-Toledano R, Gonzalez-Santander M, Arribas I, Bosch R. Diabetes - experimental models. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft137] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
25
|
Abstract
Identifying patients who are at high risk of suffering myocardial infarction can be done by determining risk factors or by the adoption of molecular genetic testing for inherited thrombophilia. We report a case of myocardial infarction at a young age. The patient complained of dyspnea (stage III) and a burning pain of severe intensity that radiated to the left retrosternal side, but was not associated with palpitations or diaphoresis. A number of biochemical parameters were normal except for an elevated creatinine phosphokinase (CPK) level. Genetic testing revealed the subject to be heterozygous for both the factor V leiden and MTHFR C677T polymorphisms. The combination of these two mutations may be a high risk factor for myocardial infarction. Genetic screening for inherited thrombophilia in young patients, especially in the presence of a common risk factor, may be useful for primary thrombopro.phylaxis and in asymptomatic relatives of patients.
Collapse
Affiliation(s)
- Najiba Fekih-Mrissa
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital, 1008 Mont Fleury, Tunis, Tunisia.
| | | | | | | | | |
Collapse
|
26
|
Berredjeb Ben Slama D, Fekih-Mrissa N, Haggui A, Nsiri B, Baraket N, Haouala H, Gritli N. Lack of association between factor V Leiden and prothrombin G20210A polymorphisms in Tunisian subjects with a history of myocardial infarction. Cardiovasc Pathol 2013; 22:39-41. [DOI: 10.1016/j.carpath.2012.03.002] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/25/2011] [Revised: 02/11/2012] [Accepted: 03/05/2012] [Indexed: 11/15/2022] Open
|
27
|
Lahmar M, Fekih-Mrissa N, Derbali H, Mansour M, Zaouali J, Mrissa R. L’encéphalopathie de Hashimoto, le diagnostic énigmatique : étude à propos de 5 cas. Rev Neurol (Paris) 2012. [DOI: 10.1016/j.neurol.2012.01.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
28
|
Fekih-Mrissa N, Klai S, Bafoun A, Nciri B, Hmida J, Gritli N. Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia. Ther Apher Dial 2011; 15:40-3. [PMID: 21272251 DOI: 10.1111/j.1744-9987.2010.00848.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Vascular access thrombosis represents a serious and common problem in hemodialysis patients. Therefore, identification of relevant thrombotic risk factors could lead to an improved antithrombotic therapy. This case control study was performed to evaluate the relationship between some thrombophilias and vascular access thrombosis in hemodialysis patients. Seventy-eight patients undergoing dialysis (between May 2007 and September 2009) were selected as subjects. This sample was divided into two groups; a case group of 28 patients who had sustained one or more thrombotic events that resulted in vascular access failure and a control group of 50 patients, who had never had a thrombotic occlusion of a functioning permanent dialysis access. Antithrombin, protein C and protein S levels were measured. Also, both groups were tested for the factor V Leiden mutation, the prothrombin G20210A mutation, the methylene tetrahydrofolate reductase C677T and A1298C mutations. Among genetic mutations of factor V Leiden, prothrombin G20210A and methylene tetrahydrofolate reductase genes, the C677T methylene tetrahydrofolate reductase mutation was the only significant genetic cause of vascular access thrombosis (P=0.005). Our data demonstrated a significantly increased risk of vascular access thrombosis in carriers of the C677T methylene tetrahydrofolate reductase mutation.
Collapse
Affiliation(s)
- Najiba Fekih-Mrissa
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital, Tunis, Tunisia.
| | | | | | | | | | | |
Collapse
|
29
|
Ben Salem-Berrabah O, Fekih-Mrissa N, Louati I, Layouni S, Zaouali J, N'siri B, Gritli N, Mrissa R. La thrombose veineuse cérébrale : étude étiologique prospective de 26 patients tunisiens. Rev Neurol (Paris) 2011; 167:141-9. [DOI: 10.1016/j.neurol.2010.06.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2010] [Revised: 05/14/2010] [Accepted: 06/18/2010] [Indexed: 10/19/2022]
|
30
|
Klai S, Fekih-Mrissa N, Rachdi R, Gritli N. The status of thrombophilic defects and non-O blood group as risk factors for gestational vascular complications among Tunisian women. Acta Haematol 2010; 125:115-20. [PMID: 21109732 DOI: 10.1159/000321934] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2010] [Accepted: 10/05/2010] [Indexed: 11/19/2022]
Abstract
AIMS Our objectives were to assess inherited thrombophilia and non-O blood group for the risk of gestational vascular complications among the Tunisian population. METHODS This study comprised 203 test subjects with adverse pregnancy outcomes including recurrent pregnancy loss, intra-uterine growth retardation, pre-eclampsia and placental abruption. Each subgroup was matched with 100 controls and analyzed separately. All patients were evaluated for factor V Leiden, factor II G20210A mutations and for non-O blood group. Protein S, protein C and antithrombin levels were determined and deficiencies noted. RESULTS The factor V Leiden mutation, non-O blood group and protein C deficiency had the highest incidences among patients both as a whole and in the 4 subgroups. The factor II G20210A mutation, protein S and antithrombin deficiencies were not statistically significant risk factors. CONCLUSION Our results provide evidence for a significant association between the factor V mutation and placental abruption. Furthermore, we found that this and the non-O blood group independently increased the risk for intra-uterine growth retardation in our population.
Collapse
Affiliation(s)
- Sarra Klai
- Laboratory of Molecular Biology, Department of Hematology, Military Hospital, Tunis, Tunisia.
| | | | | | | |
Collapse
|